Showing 6,823 results

Filters Content type: News, Editors' picks Country: United States
Activism & civil society

Gran Fury's glory: Jack Lowery discusses his book, 'It Was Vulgar & It Was Beautiful: How AIDS Activists Used Art to Fight a Pandemic'

Editor's pick
Bay Area Reporter
4 May 2022
PrEP policies & guidelines

Some Telehealth Programs Still Charge for HIV Prevention Pills

Editor's pick
POZ
4 May 2022
Changing treatment

‘The Devil You Know’: Many People Over 50 Are Taking Outdated ART, Despite Side Effects

Editor's pick
TheBodyPro
27 April 2022
People & personal stories

Transgender and Openly HIV-Positive 'Transparent' Star Alexandra Billings Discusses Her New Memoir

Editor's pick
TheBody
27 April 2022
Epidemiology & behaviour

San Francisco supervisors lift gay bathhouse prohibitions

Editor's pick
Bay Area Reporter
27 April 2022
Pharmaceutical industry

Buckle up! The ‘Staley vs Gilead’ lawsuit could cost Big Pharma billions

Editor's pick
My Fabulous Disease
26 April 2022
Harm reduction

New US Drug Control Strategy Takes Some Positive Steps But Can Go Much Further

Editor's pick
Cato Institute
22 April 2022
PrEP programmes & uptake

US: Black Women Prefer HIV Prevention Shots, But Cost is a Factor

Editor's pick
POZ
22 April 2022
Pharmaceutical industry

Gilead wins court order against fraudsters targeting HIV programme

Editor's pick
Pharmaphorum
21 April 2022
HIV in the arts & media

'PrEP Play, or Blue Parachute Strong' - strong medicine needs more regimen

Editor's pick
Bay Area Reporter
21 April 2022
Activism & civil society

Bristol Myers settles HIV antitrust suit, but J&J, Gilead still await their day in court

Editor's pick
FiercePharma
19 April 2022
Improving HIV care

New Best Practice Guide on Telehealth and HIV Care for Providers

Editor's pick
Blog
19 April 2022
Government, leadership & policy

White House’s Harold Phillips Discusses Top 5 ONAP Priorities

Editor's pick
Blog
19 April 2022
HIV prevention policy

Equity-Driven Advocacy for a National PrEP Program for Uninsured People

Editor's pick
POZ
19 April 2022
PrEP policies & guidelines

Insurers Across the US Are Often Illegally Charging for PrEP

Editor's pick
TheBody
19 April 2022
Pharmaceutical industry

Counterfeit HIV Drugs: US Justice Department Opens Investigation

Editor's pick
Medscape (requires free registration)
13 April 2022
Employment

Judge rules US military can’t discharge HIV-positive troops

Editor's pick
The Hill
11 April 2022
Cancer

Low CD4/CD8 ratio predicts increased cancer risk in people with HIV

News
11 April 2022
Coronavirus

A Rare Personal Appeal to My POZ Brothers & Sisters; Please Protect Yourself Against Covid-19

Editor's pick
AIDS Drug Assistance Program
7 April 2022
Finance & funding

Biden’s 2023 Budget Invests $9.8B in PrEP and Boosts Other HIV Funding

Editor's pick
POZ
31 March 2022
Improving HIV care

‘I’m Just Trying to Live’: Abuse and Punishment Pervade HIV Clinics

Editor's pick
TheBodyPro
31 March 2022
Injectable & long-acting HIV treatment

US: Cabenuva Approval Expanded to Include Adolescents With HIV

Editor's pick
Monthly Prescribing Reference
31 March 2022
Women

Ending HIV Criminalization Starts With Me

Editor's pick
POZ
31 March 2022
Injectable & long-acting HIV treatment

ViiV Healthcare announces label update for its long-acting HIV treatment, Cabenuva (cabotegravir, rilpivirine), to be initiated with or without an oral lead-in period

Editor's pick
ViiV press release
25 March 2022